Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda
Abstract Background Efficient testing to identify poor quality artemisinin-based combination therapy (ACT) is important to optimize efforts to control and eliminate malaria. Healthcare professionals interact with both ACT and malaria patients they treat and hence could observe, first-hand, suspect p...
Main Authors: | Helen Byomire Ndagije, Ronald Kiguba, Leonard Manirakiza, Elijah Kirabira, Allan Sserwanga, Leah Nabirye, Jackson Mukonzo, Sten Olsson, Anne Spinewine, William D’Hoore, Niko Speybroeck |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-020-3148-5 |
Similar Items
-
Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting
by: Ronald Kiguba, et al.
Published: (2020-11-01) -
The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after study.
by: Helen Byomire Ndagije, et al.
Published: (2019-01-01) -
Antitumor Research on Artemisinin and Its Bioactive Derivatives
by: Yunqin Zhang, et al.
Published: (2018-04-01) -
New orally active artemisinin dimer antimalarials
by: Mahmoud A ElSohly, et al.
Published: (2017-01-01) -
Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress
by: Qingyun Huang, et al.
Published: (2010-12-01)